v3.26.1
STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT - USD ($)
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2024 $ 144 $ 24,856 $ (6,748) $ 18,252
Balance (in Shares) at Mar. 31, 2024 1,437,500      
Net income (loss)     (156,520) (156,520)
Balance at Mar. 31, 2025 $ 144 24,856 (163,268) (138,268)
Balance (in Shares) at Mar. 31, 2025 1,437,500      
Proceeds allocated to Public Rights $ 0 5,387,388 0 5,387,388
Sale of private placement shares $ 24 2,408,456 0 2,408,480
Sale of private placement shares (in Shares) 240,848      
Issuance of representative shares $ 23 2,112,577 0 2,112,600
Issuance of representative shares (in Shares) 230,000      
Underwriters’ discount and other offering expenses $ 0 (3,264,646) 0 (3,264,646)
Accretion of carrying value to redemption value 0 (5,677,795) 0 (5,677,795)
Subsequent measurement of ordinary shares subject to redemption (interest and dividends earned on trust account)     (2,197,604) (2,197,604)
Subsequent measurement of ordinary shares subject to redemption (additional funding for business combination extension)     (450,000) (450,000)
Net income (loss) 0 0 783,344 783,344
Balance at Mar. 31, 2026 $ 191 $ 990,836 $ (2,027,528) $ (1,036,501)
Balance (in Shares) at Mar. 31, 2026 1,908,348